Zobrazeno 1 - 10 of 34 pro vyhledávání: '"Ryan R. Fleming"'
1
Akademický článek
Increasing Undergraduate Success: A Randomized Controlled Trial of U-Pace Instruction
Autor: Raymond Fleming, Laura E. Pedrick, Leah Stoiber, Sarah Kienzler, Ryan R. Fleming, Diane M. Reddy
Publikováno v: Online Learning, Vol 22, Iss 3 (2018)
U-Pace instruction, comprised of concept mastery and amplified assistance, has shown promise in increasing undergraduate success. To evaluate the efficacy of U-Pace instruction for students at-risk for college non-completion and students not at-risk
Externí odkaz: https://doaj.org/article/3457ef514bc7488cbbe0027095908221
Zobrazit plný text záznamu
3
Using U-Pace instruction to improve the academic performance of economically disadvantaged undergraduates
Autor: Dylan Barth, Diane M. Reddy, Laura E. Pedrick, Leah Stoiber, Raymond Fleming, Sarah E. Kienzler, Ryan R. Fleming, Heidi M. Pfeiffer
Publikováno v: Journal of Computer Assisted Learning. 32:304-313
This study was undertaken to evaluate whether the student success associated with the U-Pace instructional approach, which integrates mastery-based learning with proactive instructor support in an online learning environment, would replicate for both
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a7c1738c3c03a3d510f9b2d8afb82b82
https://doi.org/10.1111/jcal.12133
Zobrazit plný text záznamu
4
Increasing Undergraduate Success: A Randomized Controlled Trial of U-Pace Instruction
Autor: Leah Stoiber, Laura E. Pedrick, Sarah E. Kienzler, Raymond Fleming, Diane M. Reddy, Ryan R. Fleming
Publikováno v: Online Learning. 22
U-Pace instruction, comprised of concept mastery and amplified assistance, has shown promise in increasing undergraduate success. To evaluate the efficacy of U-Pace instruction for students at-risk for college non-completion and students not at-risk
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea15664d27fd8f5f6814c77aaf404fb4
https://doi.org/10.24059/olj.v22i3.1317
Zobrazit plný text záznamu
5
Akademický článek
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR.
Autor: Mao S; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland. shenlan.mao@astrazeneca.com john.harper@astrazeneca.com., Chaerkady R; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Yu W; Bioinformatics, AstraZeneca, Gaithersburg, Maryland., D'Angelo G; Biometrics, AstraZeneca, Gaithersburg, Maryland., Garcia A; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Chen H; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Barrett AM; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Phipps S; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Fleming R; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Hess S; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Koopmann JO; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Dimasi N; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Wilson S; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Pugh K; Spirogen, AstraZeneca, London, United Kingdom., Cook K; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Masterson LA; Spirogen, AstraZeneca, London, United Kingdom., Gao C; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Wu H; Antibody Discovery & Protein Engineering, AstraZeneca, Gaithersburg, Maryland., Herbst R; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Howard PW; Spirogen, AstraZeneca, London, United Kingdom., Tice DA; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Cobbold M; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Harper J; Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland. shenlan.mao@astrazeneca.com john.harper@astrazeneca.com.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Mar; Vol. 20 (3), pp. 541-552.
Zobrazit plný text záznamu
6
Akademický článek
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.
Autor: Chen R; Research and Development, AstraZeneca, Gaithersburg, Maryland., Rajan S; Research and Development, AstraZeneca, Gaithersburg, Maryland., Overstreet MG; Research and Development, AstraZeneca, Gaithersburg, Maryland. michael.overstreet@astrazeneca.com., Hurt EM; Research and Development, AstraZeneca, Gaithersburg, Maryland., Thomas SB; Research and Development, AstraZeneca, Gaithersburg, Maryland., Muniz-Medina V; Research and Development, AstraZeneca, Gaithersburg, Maryland., Ward C; Research and Development, AstraZeneca, Gaithersburg, Maryland., Sadowska A; Research and Development, AstraZeneca, Gaithersburg, Maryland., Fleming R; Research and Development, AstraZeneca, Gaithersburg, Maryland., Karanth S; Research and Development, AstraZeneca, Gaithersburg, Maryland., Breen S; Research and Development, AstraZeneca, Gaithersburg, Maryland., Zheng B; Research and Development, AstraZeneca, Gaithersburg, Maryland., Wu Y; Research and Development, AstraZeneca, Gaithersburg, Maryland., Iverson WO; Research and Development, AstraZeneca, Gaithersburg, Maryland., Novick S; Research and Development, AstraZeneca, Gaithersburg, Maryland., O'Day T; Research and Development, AstraZeneca, Gaithersburg, Maryland., Shah DP; Research and Development, AstraZeneca, Gaithersburg, Maryland., Dimasi N; Research and Development, AstraZeneca, Gaithersburg, Maryland., Tiberghien AC; Spirogen, London, United Kingdom., Osbourn J; Research and Development, AstraZeneca, Cambridge, United Kingdom., Walker J; Research and Development, AstraZeneca, Gaithersburg, Maryland.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Aug; Vol. 19 (8), pp. 1649-1659. Date of Electronic Publication: 2020 May 13.
Zobrazit plný text záznamu
7
Akademický článek
ADC Analysis by Hydrophobic Interaction Chromatography.
Autor: Fleming R; Antibody Discovery and Protein Engineering, Biologic Therapeutics, AstraZeneca, Gaithersburg, MD, USA. ryan.fleming@astrazeneca.com.
Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2020; Vol. 2078, pp. 147-161.
Zobrazit plný text záznamu
8
Akademický článek
Fab-Arm Exchange Combined with Selective Protein A Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly from Culture Media.
Autor: Steinhardt J; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Wu Y; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Fleming R; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Ruddle BT; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Patel P; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Wu H; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Gao C; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA., Dimasi N; Antibody Discovery and Protein Engineering, AstraZeneca, One MedImmune Way, Gaithersburg, MD 201878, USA.
Publikováno v: Pharmaceutics [Pharmaceutics] 2019 Dec 18; Vol. 12 (1). Date of Electronic Publication: 2019 Dec 18.
Zobrazit plný text záznamu
9
Editorial & Opinion
Outcomes associated with a change in clinical practice to alleviate emotional harm related to venous thromboembolism.
Autor: Jones AE; University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA; University of Utah Health, Thrombosis Service, Salt Lake City, UT, USA., Feehan M; Kantar, LLC, San Francisco, CA, USA., Fleming R; University of Utah Health, Thrombosis Service, Salt Lake City, UT, USA., Johnson SA; University of Utah Health, Thrombosis Service, Salt Lake City, UT, USA; University of Utah School of Medicine, Department of Internal Medicine, Salt Lake City, UT, USA., Witt DM; University of Utah College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA; University of Utah Health, Thrombosis Service, Salt Lake City, UT, USA. Electronic address: dan.witt@pharm.utah.edu.
Publikováno v: Thrombosis research [Thromb Res] 2019 Aug; Vol. 180, pp. 29-31. Date of Electronic Publication: 2019 Jun 01.
Zobrazit plný text záznamu
10
Akademický článek
Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
Autor: Ruddle BT; AstraZeneca, Antibody Discovery and Protein Engineering, One MedImmune Way, Gaithersburg, MD, 20878, USA., Fleming R; AstraZeneca, Antibody Discovery and Protein Engineering, One MedImmune Way, Gaithersburg, MD, 20878, USA., Wu H; AstraZeneca, Antibody Discovery and Protein Engineering, One MedImmune Way, Gaithersburg, MD, 20878, USA., Gao C; AstraZeneca, Antibody Discovery and Protein Engineering, One MedImmune Way, Gaithersburg, MD, 20878, USA., Dimasi N; AstraZeneca, Antibody Discovery and Protein Engineering, One MedImmune Way, Gaithersburg, MD, 20878, USA.
Publikováno v: ChemMedChem [ChemMedChem] 2019 Jun 18; Vol. 14 (12), pp. 1185-1195. Date of Electronic Publication: 2019 May 03.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje